XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.23.4

WARRANTS | 9 Months Ended
--- | ---
Sep. 30, 2023
Warrants |
WARRANTS | NOTE 14 – WARRANTS For the nine-month period ended September 30, 2023, no warrants were granted, and none expired. For the nine-month period ended September 30, 2023, 40,116 prefunded warrants and 1,795 granted warrants to purchase shares of common stock were exercised for a total purchase price of $1,622. See Note 13- Prefunded and Private Placement Warrants for further description. The Company uses the Black-Scholes pricing model to estimate the fair value of stock-based awards on the date of the grant. There was no compensation cost related to the warrants for the nine months ended September 30, 2023, and 2022, respectively. The Company’s outstanding and exercisable warrants As of September 30, 2023, are presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS
|  | Number Outstanding |  |  | Weighted Average Exercise Price |  |  | Contractual Life In Years |  |  | Intrinsic Value |
Warrants outstanding as of December 31, 2022 |  |  | 179,331 |  |  |  | 22.50 |  |  |  | 4.72 |  |  |  | 6,731 |
Warrants granted |  |  |  |  |  |  | - |  |  |  | - |  |  |  | - |
Warrants forfeited, expired, cancelled |  |  |  |  |  |  | - |  |  |  | - |  |  |  | - |
Warrants exercised |  |  | (1,795 | ) |  |  | 22.50 |  |  |  | - |  |  |  | - |
Warrants outstanding as of September 30, 2023 |  |  | 177,536 |  |  |  | 22.50 |  |  |  | 4.02 |  |  |  | 0 |
Warrants exercisable as of September 30, 2023 |  |  | 177,536 |  |  |  | 22.50 |  |  |  | 4.02 |  |  |  | - |

X
- References No definition available. + Details
Name: | MEDS_DisclosureWarrantsAbstract
Namespace Prefix: | MEDS_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants [Text Block] + References No definition available. + Details
Name: | MEDS_WarrantsTextBlock
Namespace Prefix: | MEDS_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration